Pharmacokinetic Study of Weekly (Days 1-5) Low-dose S-1 in Patients with Non-Small-Cell Lung Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1876-1038|7|2|167-172

ISSN： 1574-8871

Source： Reviews on Recent Clinical Trials, Vol.7, Iss.2, 2012-05, pp. : 167-172

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dose Escalation and Pharmacokinetic Study of Carboplatin plus Pemetrexed for Elderly Patients with Advanced Nonsquamous Non-Small-Cell Lung Cancer: Kumamoto Thoracic Oncology Study Group Trial 1002

By  

Oncology, Vol. 88, Iss. 4, 2014-12 ,pp. : 201-207

Karger

Access to resources Recommend Favorite

Continuous Administration of Daily Low-Dose Temozolomide in Pretreated Patients with Advanced Non-Small Cell Lung Cancer: A Phase II Study

By  

Oncology, Vol. 76, Iss. 2, 2009-01 ,pp. : 112-117

Karger

Access to resources Recommend Favorite

Phase II Study of Weekly Paclitaxel in Patients with Non-Small Cell Lung Cancer Who Have Failed Previous Treatments

By  

Oncology, Vol. 66, Iss. 5, 2004-09 ,pp. : 347-352

Karger

Access to resources Recommend Favorite

Short Schedule of Cisplatin and Vinorelbine: A Dose-Finding Study in Non-Small-Cell Lung Cancer

By  

Oncology, Vol. 71, Iss. 3-4, 2007-07 ,pp. : 229-236

Karger

Access to resources Recommend Favorite

Rechnitzer S, et al.: Pretreatment Prognostic Factors for Survival in Non-Small-Cell Lung Cancer: A Multivariate Analysis of 229 Patients. Onkologie 1998;21:204–209. Is there a Need for New Prognostic Factors in Non-Small-Cell Lung Cancer?

By  

Oncology Research and Treatment, Vol. 21, Iss. 3, 1998-07 ,pp. : 248-248

Karger

Access to resources Recommend Favorite